E
CORT icon

Ergoteles’s Corcept Therapeutics CORT Stock Holding History

Ergoteles’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-46,489
Closed -$1.11M – 1610
2022
Q2 		$1.11M Sell
46,489
-5,860
-11% -$128K 0.03% 506
2022
Q1 		$1.18M Sell
52,349
-26,449
-34% -$563K 0.04% 382
2021
Q4 		$1.56M Buy
78,798
+68,660
+677% +$1.39M 0.06% 311
2021
Q3 		$200K Sell
10,138
-18,171
-64% -$380K 0.01% 1005
2021
Q2 		$623K Buy
+28,309
New +$630K 0.01% 696

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return